Sleep Apnea, Obstructive Completed Phase 2 Trials for Tiagabine (DB00906)

IndicationStatusPhase
DBCOND0030275 (Sleep Apnea, Obstructive)Completed2
clinicaltrials.gov IdentifierTitlePurposeDrugs
NCT02387710Tiagabine to Enhance Slow Wave Sleep in Patients With Sleep ApneaTreatment